NEW
YORK, July 22, 2024 /PRNewswire/ -- The
global high throughput screening (HTS) market size is
estimated to grow by USD 19.9 billion
from 2024-2028, according to Technavio. The market is
estimated to grow at a CAGR of almost 12.12% during the
forecast period. Rise in R and D investments is driving
market growth, with a trend towards increasing focus on
promotional activities. However, shortage of trained
healthcare professionals poses a challenge. Key market
players include Agilent Technologies Inc., Aurora Biomed Inc.,
Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat
Srl, BMG LABTECH GmbH, Charles River Laboratories International
Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o,
HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd.,
Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc.,
Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher
Scientific Inc..
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Application (Target
identification and validation, Primary and secondary screening,
Toxicology assessment, and Stem cell research), End-user
(Pharmaceutical and biotechnology companies, Academic and research
institutes, and CROs), and Geography (North America, Europe, Asia,
and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Agilent Technologies
Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad
Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River
Laboratories International Inc., Corning Inc., Danaher Corp., DIANA
Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC,
Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH,
PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and
Thermo Fisher Scientific Inc.
|
Key Market Trends Fueling Growth
The High Throughput Screening (HTS) market faces unique
challenges due to the specialized nature of its products and niche
end-users. Brand and product visibility play a limited role in
sales. Instead, vendors focus on enhancing their distribution
networks and ensuring product availability. HTS advertising and
marketing are restricted, and awareness is lacking. Thermo Fisher
Scientific and Bio-Rad Laboratories use websites, documents,
brochures, and interactive videos on YouTube to educate end-users.
Workshops are also being conducted to increase awareness. Advanced
product development is leading market participants to recognize the
importance of promotional activities and awareness programs. These
factors are expected to boost the global HTS market during the
forecast period.
High-throughput screening (HTS) is a key trend in the biotech
industry, enabling researchers to test large compound libraries for
potential drug candidates. Pharmaceutical corporations, biotech
startups, academic institutions, and research organizations are
leveraging HTS to tackle complex illnesses like cancer and
neurological disorders. HTS involves using specialized equipment
such as robotic arms, microplate readers, and high-resolution
imaging systems for automating target identification and data
analysis. Data analytics plays a crucial role in HTS, with machine
learning and data management systems used for data organization,
retrieval, integration, and storage. Carrier screening market and
stem cell research also benefit from HTS. Drug repurposing
initiatives, like Adcetris from Seagen, are gaining traction, and
collaborative networks among HTS service providers facilitate open
innovation models. The biopharmaceutical industry's focus on
precision medicine drives the demand for HTS, with companies
investing in computing foundations and chemical databases to
support genomic data analysis. Despite advancements, challenges
such as false-positive findings and maintenance of specialized
equipment persist. The global healthcare sector continues to
embrace HTS, fueling growth in this market. Companies like Relay
Therapeutics and Biotechnology startups are leading the charge in
HTS-driven drug discovery. Toxicology and open innovation models
further expand HTS applications.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- The High Throughput Screening (HTS) market faces challenges due
to the shortage of skilled professionals in pharmaceutical and
biotechnology facilities and laboratories. HTS requires specialized
expertise to operate the sensitive equipment and conduct tests
effectively. In developing countries, the healthcare system lacks
the necessary resources and trained personnel, which hinders the
adoption of HTS technology. The absence of skilled technicians can
lead to non-compliance, product failures, and significant financial
losses for companies. Additionally, the poor healthcare
infrastructure and low awareness about advanced technologies in
these regions further impede the growth of the HTS market.
Government investment in improving healthcare facilities and
promoting awareness about HTS technology could help address these
challenges and drive market expansion.
- The High-Throughput Screening (HTS) market is a significant
segment of the biotechnology industry, serving the needs of pharma
companies, research organizations, and biopharmaceutical industry
players. The market faces challenges in areas like carrier
screening, target identification, and drug repurposing initiatives.
Machine learning and open innovation models are being adopted to
overcome these challenges. Relay Therapeutics, a biotech startup,
is leveraging HTS for drug discovery using cell-based assays and
label-free technology. HTS involves using instruments like robotic
arms and microplate readers, along with software and services for
data management, storage, organization, retrieval, and integration.
Consumables, chemical databases, genomic data, and detection
techniques are essential components. HTS is used in stem cell
research, toxicology, and precision medicine, and collaborative
networks help share knowledge and resources. HTS service providers
offer a range of products and services, including instruments,
software, and consumables, to support drug development and clinical
trials. Technology advancements include lab-on-a-chip and
biochemical screening. The global healthcare sector stands to
benefit significantly from these innovations.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This high throughput screening (hts) market report extensively
covers market segmentation by
- Application
- 1.1 Target identification and validation
- 1.2 Primary and secondary screening
- 1.3 Toxicology assessment
- 1.4 Stem cell research
- End-user
- 2.1 Pharmaceutical and biotechnology companies
- 2.2 Academic and research institutes
- 2.3 CROs
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Target identification and validation- The
global High Throughput Screening (HTS) market is driven by the
increasing burden of chronic diseases, such as cardiovascular
diseases, cancer, and respiratory diseases, which necessitates
early and comprehensive target identification and validation.
Pharmaceutical companies are continuously outsourcing target
identification and validation services to meet the rising demand
for accurate analytical details on drugs and process development by
regulatory agencies. The segment's growth is further fueled by the
increasing pipeline for biological candidates and advancements in
target identification and validation using advanced bioinformatics
tools, automated experimental designs, and AI and ML algorithms.
These factors are expected to foster the growth of the target
identification and validation segment in the global HTS market
during the forecast period.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global Toxicology Testing Market is experiencing significant
growth due to rising awareness of drug safety and stringent
regulatory policies. Meanwhile, the global Genome Editing Market is
expanding rapidly, driven by advancements in CRISPR technology and
increased investment in genetic research. Additionally, the global
Modular Laboratory Automation Market is thriving as laboratories
seek efficient, scalable solutions to enhance productivity and
accuracy. Together, these markets represent pivotal areas in the
biotechnology and healthcare sectors, fostering innovation and
improving outcomes across various scientific and medical
disciplines.
Research Analysis
High-throughput screening (HTS) is a critical technology in the
field of drug discovery and research, enabling the rapid and
efficient identification of potential therapeutic compounds. HTS
utilizes large compound libraries, often numbering in the millions,
to screen for compounds that exhibit desirable biological activity.
Academic institutions and biotech startups collaborate with
pharmaceutical corporations to leverage their expertise and
resources in this area. Complex illnesses such as cancer and
neurological disorders are major targets for HTS, with a focus on
developing new treatments and repurposing existing drugs. Robotic
arms, microplate readers, high-resolution imaging systems, and data
management systems are essential tools in the HTS process. Data
analytics plays a crucial role in organizing, retrieving,
integrating, and storing data from HTS experiments. Chemical
databases, research organizations, toxicology, open innovation
models, and the global healthcare sector are also integral
components of the HTS market. Adcetris from Seagen is an example of
a successful drug discovered through HTS. Drug repurposing, stem
cell research, and data retrieval are other areas of focus in the
HTS market.
Market Research Overview
High Throughput Screening (HTS) is a critical technology in the
life sciences sector, enabling the rapid and efficient
identification of potential drug candidates for complex illnesses
such as cancer and neurological disorders. HTS utilizes compound
libraries, automation, and specialized equipment like robotic arms,
microplate readers, and high-resolution imaging systems to screen
large numbers of compounds against specific targets. Data analytics
plays a crucial role in HTS, with machine learning and data
management systems used to organize, retrieve, integrate, and
analyze vast amounts of genomic data and chemical information.
Collaborative networks and HTS service providers facilitate open
innovation models and knowledge sharing among academic
institutions, biotech startups, pharmaceutical corporations, and
research organizations. Drug repurposing initiatives, such as those
by Biotechnology startups like Relay Therapeutics, offer new
opportunities for discovering existing drugs with potential
applications for new diseases. The biopharmaceutical industry,
global healthcare sector, and precision medicine are major markets
for HTS, with a focus on detection techniques, clinical trials, and
the development of products and services including consumables,
software, and services. Technology advancements like cell-based
assays, lab-on-a-chip, and label-free technology continue to drive
innovation in HTS. Toxicology and stem cell research are also
significant applications of HTS. Overall, HTS is a vital component
of drug discovery and development, contributing to the advancement
of new treatments for chronic diseases and other health
conditions.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Target Identification And Validation
- Primary And Secondary Screening
- Toxicology Assessment
- Stem Cell Research
- End-user
-
- Pharmaceutical And Biotechnology Companies
- Academic And Research Institutes
- CROs
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/high-throughput-screening-hts-market-size-is-set-to-grow-by-usd-19-9-billion-from-2024-2028--rise-in-r-and-d-investments-to-boost-the-market-growth-technavio-302202266.html
SOURCE Technavio